Ancillary testing, diagnostic/classification criteria and severity grading in Behçet disease

Annabelle A. Okada, Miles Stanford, Khalid Tabbara

Research output: Contribution to journalArticle

Abstract

Since there is no pathognomonic clinical sign or laboratory test to distinguish Behçet disease from other uveitic entities, the diagnosis must be made based on characteristic ocular and systemic findings in the absence of evidence of other disease that can explain the findings. Ancillary tests, including ocular and brain imaging studies, are used to assess the severity of intraocular inflammation and systemic manifestations of Behçet disease, to identify latent infections and other medical conditions that might worsen with systemic treatment, and to monitor for adverse effects of drugs used. There are two diagnostic or classification criteria in general use by the uveitis community, one from Japan and one from an international group; both rely on a minimum number and/or combination of clinical findings to identify Behçet disease. Finally, several grading schemes have been proposed to assess severity of ocular disease and response to treatment.

Original languageEnglish (US)
Pages (from-to)387-393
Number of pages7
JournalOcular Immunology and Inflammation
Volume20
Issue number6
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Eye Diseases
Uveitis
Neuroimaging
Japan
Inflammation
Infection
Pharmaceutical Preparations

Keywords

  • Behçet disease
  • Diagnostic criteria
  • Ocular imaging
  • Pathergy test
  • Retinal vasculitis

ASJC Scopus subject areas

  • Ophthalmology
  • Immunology and Allergy

Cite this

Ancillary testing, diagnostic/classification criteria and severity grading in Behçet disease. / Okada, Annabelle A.; Stanford, Miles; Tabbara, Khalid.

In: Ocular Immunology and Inflammation, Vol. 20, No. 6, 12.2012, p. 387-393.

Research output: Contribution to journalArticle

Okada, Annabelle A. ; Stanford, Miles ; Tabbara, Khalid. / Ancillary testing, diagnostic/classification criteria and severity grading in Behçet disease. In: Ocular Immunology and Inflammation. 2012 ; Vol. 20, No. 6. pp. 387-393.
@article{e074249ccc4c455b8fa2b54ea130114d,
title = "Ancillary testing, diagnostic/classification criteria and severity grading in Beh{\cc}et disease",
abstract = "Since there is no pathognomonic clinical sign or laboratory test to distinguish Beh{\cc}et disease from other uveitic entities, the diagnosis must be made based on characteristic ocular and systemic findings in the absence of evidence of other disease that can explain the findings. Ancillary tests, including ocular and brain imaging studies, are used to assess the severity of intraocular inflammation and systemic manifestations of Beh{\cc}et disease, to identify latent infections and other medical conditions that might worsen with systemic treatment, and to monitor for adverse effects of drugs used. There are two diagnostic or classification criteria in general use by the uveitis community, one from Japan and one from an international group; both rely on a minimum number and/or combination of clinical findings to identify Beh{\cc}et disease. Finally, several grading schemes have been proposed to assess severity of ocular disease and response to treatment.",
keywords = "Beh{\cc}et disease, Diagnostic criteria, Ocular imaging, Pathergy test, Retinal vasculitis",
author = "Okada, {Annabelle A.} and Miles Stanford and Khalid Tabbara",
year = "2012",
month = "12",
doi = "10.3109/09273948.2012.723111",
language = "English (US)",
volume = "20",
pages = "387--393",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Ancillary testing, diagnostic/classification criteria and severity grading in Behçet disease

AU - Okada, Annabelle A.

AU - Stanford, Miles

AU - Tabbara, Khalid

PY - 2012/12

Y1 - 2012/12

N2 - Since there is no pathognomonic clinical sign or laboratory test to distinguish Behçet disease from other uveitic entities, the diagnosis must be made based on characteristic ocular and systemic findings in the absence of evidence of other disease that can explain the findings. Ancillary tests, including ocular and brain imaging studies, are used to assess the severity of intraocular inflammation and systemic manifestations of Behçet disease, to identify latent infections and other medical conditions that might worsen with systemic treatment, and to monitor for adverse effects of drugs used. There are two diagnostic or classification criteria in general use by the uveitis community, one from Japan and one from an international group; both rely on a minimum number and/or combination of clinical findings to identify Behçet disease. Finally, several grading schemes have been proposed to assess severity of ocular disease and response to treatment.

AB - Since there is no pathognomonic clinical sign or laboratory test to distinguish Behçet disease from other uveitic entities, the diagnosis must be made based on characteristic ocular and systemic findings in the absence of evidence of other disease that can explain the findings. Ancillary tests, including ocular and brain imaging studies, are used to assess the severity of intraocular inflammation and systemic manifestations of Behçet disease, to identify latent infections and other medical conditions that might worsen with systemic treatment, and to monitor for adverse effects of drugs used. There are two diagnostic or classification criteria in general use by the uveitis community, one from Japan and one from an international group; both rely on a minimum number and/or combination of clinical findings to identify Behçet disease. Finally, several grading schemes have been proposed to assess severity of ocular disease and response to treatment.

KW - Behçet disease

KW - Diagnostic criteria

KW - Ocular imaging

KW - Pathergy test

KW - Retinal vasculitis

UR - http://www.scopus.com/inward/record.url?scp=84870952485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870952485&partnerID=8YFLogxK

U2 - 10.3109/09273948.2012.723111

DO - 10.3109/09273948.2012.723111

M3 - Article

C2 - 23163622

AN - SCOPUS:84870952485

VL - 20

SP - 387

EP - 393

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 6

ER -